In the fast-paced world of semiconductor manufacturing, achieving higher yields and reducing costs are constant challenges. Ideally, yield should only be impacted by unavoidable defects when ...

What is Real-Time Release Testing? Real-Time Release Testing (RTRT) is an advanced approach to biopharmaceutical manufacturing quality control that improves upon current systems. RTRT is defined as ...

The transition to the 2nm technology node introduces unprecedented challenges in Automated Test Equipment (ATE) bring-up and manufacturability. As semiconductor devices scale down, the complexity of ...

Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

SAN FRANCISCO/SINGAPORE, March 3 (Reuters) - Chip designers Nvidia (NVDA.O), opens new tab and Broadcom (AVGO.O), opens new tab are running manufacturing tests with Intel (INTC.O), opens new tab, two ...

Tell us about the control strategy you've implemented with AstraZeneca and its external partners. Over the last year, we worked to improve our control strategy for drug delivery devices. Our goal was ...

A new chip manufacturing process from Intel Corp. failed to meet Broadcom Inc.’s expectations in a recent evaluation, Reuters reported today. The development may mark a setback for Intel’s foundry ...

For many decades, businesses have focused their manufacturing operations in faraway production locations where labor and shipping costs are traditionally more affordable. However, recent global ...

When pharmaceutical companies develop a novel drug for the market, several steps are required to assess and regulate its safety, effectiveness, manufacturability, and reliability. These processes, and ...